Centene Corp Receives a New Rating from Top Analyst

By Carrie Williams

In a report released today, David Windley from Jefferies reiterated a Buy rating on Centene Corp (NYSE: CNC), with a price target of $83. The company’s shares opened today at $70.64.

According to TipRanks.com, Windley is a top 100 analyst with an average return of 15.8% and a 74.8% success rate. Windley covers the Healthcare sector, focusing on stocks such as Quintiles Transnational, WellCare Health Plans, and PRA Health Sciences.

Centene Corp has an analyst consensus of Moderate Buy, with a price target consensus of $78.13.

Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CNC in relation to earlier this year. Most recently, in October 2016, Michael Neidorff, the COB, Pres & CEO of CNC bought 25,000 shares for a total of $315,000.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs, including Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.